Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Elizabeth Sainsbury"'
Autor:
Elizabeth Sainsbury, Ronaldo do Amaral, Alexander W. Blayney, Rory McConn Walsh, Fergal J. O'Brien, Cian O'Leary
Publikováno v:
Biomaterials and Biosystems, Vol 6, Iss , Pp 100046- (2022)
Despite the high success rate of autologous grafts in tympanic membrane repair, clinical alternatives are required for the closure of unresponsive chronic perforations that can lead to recurring infection and hearing loss. Tissue engineering and rege
Externí odkaz:
https://doaj.org/article/7ad9e81b2702444bac21e692c196e5c9
Publikováno v:
Methods in Molecular Biology ISBN: 9781071628225
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6bc5bae12b36f58adc6d5635b5575fd
https://doi.org/10.1007/978-1-0716-2823-2_14
https://doi.org/10.1007/978-1-0716-2823-2_14
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2595
Assessment of cell cytotoxicity following transfection of cells with microRNA (miRNA) is an essential step in the evaluation of basic miRNA functional effects within cells in both 2D and 3D microenvironments. The lactate dehydrogenase (LDH) assay is
Autor:
Manish R. Patel, Suzanne F. Jones, Jay Yang, Julie Charlton, William B. Donnellan, Ehab Atallah, Philip Overend, Jon Travers, Simon Smith, Giulia Fabbri, J. Elizabeth Pease, Carrie A. Adelman, Alexander MacDonald, Donald K. Strickland, Elizabeth Sainsbury, Gautam Borthakur, Adam S. Asch, Alireza Eghtedar, Jan Cosaert, Anna Korzeniowska
Publikováno v:
Blood. 134:3919-3919
Background: Aurora kinases (AurK) represent potential targets for anticancer therapy in hematological malignancies and solid tumors. AurK B inhibitor AZD1152 (barasertib) showed benefit (35% CR/CRi) in patients (pts) with untreated AML when given as
Autor:
Carrie A. Adelman, Manish R. Patel, Ehab Atallah, J. Elizabeth Pease, Suzanne F. Jones, Julie Charlton, Elena Young, Wolfram Brugger, Philip Overend, Donald K. Strickland, Alexander MacDonald, Jon Travers, Elizabeth Sainsbury, Simon Smith, Adam S. Asch, William B. Donnellan
Publikováno v:
Blood. 132:4064-4064
Background: Aurora kinases represent potential targets for anticancer therapy in solid tumors and hematological malignancies. In a phase I/II study, the aurora B kinase inhibitor AZD1152 (barasertib) showed benefit (35% CR/CRi) in patients (pts) with
Autor:
Rolf M. Zinkernagel, Andrew J. Macpherson, Dominique Gatto, Hans Hengartner, Elizabeth Sainsbury, Gregory R. Harriman
Publikováno v:
Science (New York, N.Y.). 288(5474)
The immunoglobulin A (IgA) is produced to defend mucosal surfaces from environmental organisms, but host defenses against the very heavy load of intestinal commensal microorganisms are poorly understood. The IgA against intestinal commensal bacterial